JW Pharmaceutical Corporation (KRX:001065)

JW Pharmaceutical Statistics

Total Valuation

KRX:001065 has a market cap or net worth of KRW 707.93 billion. The enterprise value is 701.22 billion.

Market Cap	707.93B
Enterprise Value	701.22B

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	Mar 31, 2026

Share Statistics

Current Share Class	337,418
Shares Outstanding	n/a
Shares Change (YoY)	-1.32%
Shares Change (QoQ)	+22.32%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	8.23%
Float	12.90M

Valuation Ratios

The trailing PE ratio is 11.51.

PE Ratio	11.51
Forward PE	n/a
PS Ratio	0.91
PB Ratio	1.92
P/TBV Ratio	1.99
P/FCF Ratio	8.37
P/OCF Ratio	7.34
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.44, with an EV/FCF ratio of 8.29.

EV / Earnings	11.40
EV / Sales	0.90
EV / EBITDA	6.44
EV / EBIT	7.78
EV / FCF	8.29

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.15.

Current Ratio	1.42
Quick Ratio	0.86
Debt / Equity	0.15
Debt / EBITDA	0.51
Debt / FCF	0.65
Interest Coverage	19.86

Financial Efficiency

Return on equity (ROE) is 17.60% and return on invested capital (ROIC) is 17.31%.

Return on Equity (ROE)	17.60%
Return on Assets (ROA)	9.08%
Return on Invested Capital (ROIC)	17.31%
Return on Capital Employed (ROCE)	22.18%
Weighted Average Cost of Capital (WACC)	10.25%
Revenue Per Employee	725.93M
Profits Per Employee	57.59M
Employee Count	1,068
Asset Turnover	1.28
Inventory Turnover	3.75

Taxes

In the past 12 months, KRX:001065 has paid 27.32 billion in taxes.

Income Tax	27.32B
Effective Tax Rate	30.76%

Stock Price Statistics

The stock price has decreased by -7.05% in the last 52 weeks. The beta is 1.16, so KRX:001065's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-7.05%
50-Day Moving Average	28,351.00
200-Day Moving Average	28,527.75
Relative Strength Index (RSI)	37.82
Average Volume (20 Days)	548

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:001065 had revenue of KRW 775.30 billion and earned 61.51 billion in profits. Earnings per share was 2,534.00.

Revenue	775.30B
Gross Profit	359.31B
Operating Income	87.88B
Pretax Income	88.84B
Net Income	61.51B
EBITDA	106.62B
EBIT	87.88B
Earnings Per Share (EPS)	2,534.00

Balance Sheet

The company has 61.34 billion in cash and 54.63 billion in debt, with a net cash position of 6.71 billion.

Cash & Cash Equivalents	61.34B
Total Debt	54.63B
Net Cash	6.71B
Net Cash Per Share	n/a
Equity (Book Value)	369.37B
Book Value Per Share	13,194.16
Working Capital	87.35B

Cash Flow

In the last 12 months, operating cash flow was 96.40 billion and capital expenditures -11.77 billion, giving a free cash flow of 84.62 billion.

Operating Cash Flow	96.40B
Capital Expenditures	-11.77B
Free Cash Flow	84.62B
FCF Per Share	n/a

Margins

Gross margin is 46.35%, with operating and profit margins of 11.33% and 7.93%.

Gross Margin	46.35%
Operating Margin	11.33%
Pretax Margin	11.46%
Profit Margin	7.93%
EBITDA Margin	13.75%
EBIT Margin	11.33%
FCF Margin	10.92%

Dividends & Yields

This stock pays an annual dividend of 675.00, which amounts to a dividend yield of 2.41%.

Dividend Per Share	675.00
Dividend Yield	2.41%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	6
Payout Ratio	17.99%
Buyback Yield	1.32%
Shareholder Yield	3.73%
Earnings Yield	8.69%
FCF Yield	11.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

KRX:001065 has an Altman Z-Score of 3.79 and a Piotroski F-Score of 6.

Altman Z-Score	3.79
Piotroski F-Score	6